Asston Pharmaceuticals Ltd — Important, 02-07-2026: Company Update

Asston Pharmaceuticals' board approved a preferential issue of up to 24,10,431 equity shares at ₹115 each to non-promoter investors. This capital raising move totals ₹27.72 Cr. The funds, subject to shareholder approval at an upcoming Extraordinary General Meeting, are intended to strengthen the company's financial position. This strategic decision aims to bolster business operations and future growth initiatives, providing new capital from a diverse investor base.